Bausch Health Companies | VRX - Marktkapitalisierung

Aktienkurs
7.42
Täglich Wechseln
0.09 1.16%
Monatlich
-6.02%
Jährlich
13.90%
Q2 Prognose
7.72




Marktkapitalisierung Veränderung Datum
Amgen USD 189.89B 13.64B 2026-03
ANI Pharmaceuticals USD 1.69B 57M 2026-05
Aurora Cannabis CAD 327.21M 142.93M 2025-12
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Canopy Growth CAD 656.46M 124.89M 2025-12
Corcept Therapeutics USD 4.32B 654M 2026-03
Danaher USD 128.46B 33.24B 2026-03
Drreddys Laboratories INR 11.69B 50M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Gilead Sciences USD 167.39B 5.6B 2026-05
Nektar Therapeutics USD 15.62B 14.76B 2026-05
Novo Nordisk A/S DKK 1.45T 421.31B 2026-05
Pacira USD 915M 149M 2026-03
Perrigo USD 1.58B 265M 2026-05
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.97B 105M 2025-12
Supernus Pharmaceuticals USD 2.82B 155M 2026-05
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05
Zoetis USD 39.98B 9.73B 2026-05